资讯

PipelineReview.com1 天

RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug ...

YANTAI, China I August 18, 2025 I RemeGen Co., Ltd. (Stock Code: 688331.SH/09995.HK, "RemeGen"), a leading Chinese biopharmaceutical company, announced today ...